Septo-optic dysplasia

Pediatr Endocrinol Rev. 2010 Sep;8(1):18-24.

Abstract

Septo-optic dysplasia is a rare disorder characterized by optic nerve hypoplasia; midline developmental defects including agenesis of the septum pellucidum, thinning or absence of the corpus callosum, or both; and deficiencies of pituitary hormones. The majority of cases are sporadic but rare familial cases occur. The clinical manifestations include poor visual function in one or both eyes, developmental delay, seizures, sleep disturbances, and precocious puberty. A life-long multidisciplinary approach is crucial in the management of these patients to optimize their growth and development and to help them lead as normal lives as possible.

Publication types

  • Review

MeSH terms

  • Adrenocorticotropic Hormone / deficiency
  • Child, Preschool
  • Female
  • Growth Hormone / deficiency
  • Homeodomain Proteins / genetics
  • Humans
  • Hypopituitarism / genetics
  • Hypopituitarism / physiopathology*
  • Hypopituitarism / therapy
  • Infant
  • Male
  • Optic Nerve / abnormalities*
  • Optic Nerve / physiopathology
  • Septo-Optic Dysplasia / diagnosis
  • Septo-Optic Dysplasia / genetics
  • Septo-Optic Dysplasia / physiopathology*
  • Septo-Optic Dysplasia / therapy*
  • Septum Pellucidum / abnormalities*
  • Septum Pellucidum / physiopathology
  • Thyrotropin / deficiency
  • Visual Acuity / physiology

Substances

  • HESX1 protein, human
  • Homeodomain Proteins
  • Adrenocorticotropic Hormone
  • Thyrotropin
  • Growth Hormone